It is noteworthy in this context that calreticulin is found in a complex with APP and Aβ [30], [31] and that levels of the calreticulin mRNA and protein are reduced in patients with AD, suggesting that calreticulin is implicated also in the proteolytic processing of APP and, thus, in AD pathogenesis [32]. This evidence concerns the gene APP and Alzheimer disease.